The Lawyer’s new China Elite report contains the most detailed research available on the PRC legal market and contains unparalleled insight into the country's leading law firms. They vary in size, practice focus and geographic coverage, but they all share one common quality – ambition... Read more
An exhaustive analysis of the UK market including every firm in the top 200 ranked, analysed and benchmarked, UK chambers ranked by turnover, revenue per barrister and which international firms are most active in the UK.
Sorin, the medical technology company recently spun-off by Italian conglomerate Snia, has appointed Oppen-heimer Wolff & Donnelly partner Bryan Sheridan as its new head of legal.
Sorin, the medical technology company recently spun off by Italian conglomerate Snia, has appointed Oppenheimer Wolff & Donnelly partner Bryan Sheridan as its new head of legal.
Sheridan, a UK-qualified barrister and life sciences specialist, will focus on building Sorin’s two-lawyer legal department, which is expected to double in size this year.
Sheridan plans to review the way in which the company outsources legal work and to reduce the number of external firms instructed.
“Part of my brief is to see how we use external lawyers and to balance that with building an in-house team. Like any other legal department, we want to make efficient use of our external lawyers,” said Sheridan.
Sorin has relationships with around 30 firms, based in a number of jurisdictions, including Italy and the US, although 60 per cent of the company’s legal work is farmed out to just 10 of these firms, including Milan-based Chiomenti.
“There will be a reduction in the number of law firms we use. That’s without a doubt,” added Sheridan.
Sorin, advised by Chiomenti, floated on the Milan Stock Exchange last Monday (5 January), making it the first company to be listed in Europe this year.
Sheridan, whose title is now director of corporate legal affairs, was based in Oppen-heimer’s Brussels office.